UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED) MAY 13, 2003 ASTRO-MED, INC (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) COMMISSION FILE NUMBER 0-13200 RHODE ISLAND 05-0318215 (STATE OR OTHER JURISDICTION OF (IRS EMPLOYER IDENTIFICATION INCORPORATION OR ORGANIZATION) NUMBER) 600 EAST GREENWICH AVENUE, WEST WARWICK, RI 02893 (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES, INCLUDING ZIP CODE) (401-828-4000) (REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE) ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS (c) Exhibit Exhibit no. Exhibit 99.1 Press Release dated May 13, 2003 ITEM 9. REGULATION FD DISCLOSURE AND ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION In accordance with Securities and Exchange Commission Release No. 33-8126, the following information, which is intended to be furnished under Item 12, "Results of Operations and Financial Condition", is instead being furnished under Item 9, "Regulation FD Disclosure." This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. On May 13, 2003, Astro-Med, Inc. issued a press release in which it disclosed unaudited financial information related to first quarter consolidated earnings. A copy of the press release relating to such announcement, dated May 13, 2003, is attached hereto as Exhibit 99.1 and is incorporated herein by reference. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned thereunto duly authorized. DATE: May 16, 2003 ASTRO-MED, INC. By: /s/ Joseph P. O'Connell ------------------------ Vice President and Treasurer Chief Financial Officer INDEX TO EXHIBITS Exhibit No. Exhibit ----------- ------- 99.1 Press Release Dated May 13, 2003 Exhibit 99.1 - Press Release ---------------------------- - -------------------------------------------------------------------------------- PRESS RELEASE - -------------------------------------------------------------------------------- [OBJECT OMITTED] 600 East Greenwich Avenue West Warwick, Rhode Island 02893 Astro-Med Estimates Strong Sales and Profit for the First Quarter Contact: Albert W. Ondis, CEO Joseph P. O'Connell, CFO May 13, 2003 Astro-Med, Inc. (401) 828-4000 West Warwick, RI -- Astro-Med, Inc. (NASDAQ:ALOT) announced today it expects to report sales of $13.2 million for the First Quarter ended May 3, 2003, an increase of 16% over the $11.4 million reported for the corresponding quarter of the prior year. The Company anticipates net income of approximately $500,000, equal to 12 cents per share, for the Quarter compared to a net loss of $632,000, equal to 15 cents per share, for the corresponding Quarter of the prior year. Commenting on the First Quarter, Albert W. Ondis, Chairman and Chief Executive Officer stated: "Coming on the heels of the excellent operating results of the Fourth Quarter, when we reported sales of $12.9 million, this quarter exemplifies continuing progress. We are very gratified to report that incoming new orders, including the Airbus order that we recently announced, reached a record $15.0 million in the quarter. This is an all-time high and is a further sign that our new products are being well received in the marketplace." The Company's actual results for the First Quarter will be released on Tuesday, May 20, 2003 and management will discuss the results in detail during our conference call on May 21, 2003 at 11:00 AM EDT. The conference will be broadcast in real time over the Internet. Access is available through the Company's website at www.astromed.com. Astro-Med, Inc. is a leading manufacturer of high tech specialty printing systems, electronic medical instrumentation, and test and measurement instruments employed around the world in a wide range of industrial, scientific and medical applications. # # # Safe Harbor Statement This news release contains forward-looking statements, and actual results may vary from those expressed or implied herein. Factors that could affect these results include those mentioned in Astro-Med's FY2003 annual report and its annual and quarterly filings with the Securities and Exchange Commission.
AstroNova (ALOT) 8-KFinancial statements and exhibits
Filed: 16 May 03, 12:00am